StockWireNews

Today's Bell Watch: Low Float (MDAI) Is A Nasdaq Predictive AI Company With A $100Mn Contract

January 3rd

Greetings Readers,

Right now, a new breakout idea hits your screens in the form of a Nasdaq AI profile.

And when it comes to profiles with low floats this small, full attention/focus is required.

Yahoo Finance is reporting this profile to have fewer than 7Mn shares in its float which means volatility could appear in a blink.

But this isn't only a low float profile, there are a handful of other potential catalysts that could provide it with a breakout spark.

How about a recent uplisting to the Nasdaq Capital Market marking a significant milestone and spotlight grabbing move?

Yup. This profile could soon be on Wall Street's immediate radar.

What about becoming the recipient of a mind-boggling Multi-Mn-Dollar contract?

That's right. It's got that, too!

Listen. The clock's ticking to pull up: *Spectral AI, Inc. (MDAI)*

Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers.

And based on 3 key potential catalysts, MDAI requires full focus. Here's a quick list:

#1. A Low Float Could Provide The Potential For Wild Volatility.

#2. A Game-Changing Contract Awarded To MDAI For Over $100Mn To Advance DeepView® System!

#3. MDAI Looks To Capitalize On A Strong 2023 Full Of Important Company Maneuvers.

But more on those in a second...

The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System.

DeepView® is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention.

With algorithm-driven results and a goal of substantially exceeding the current standard of care in the future, DeepView® is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs.

DeepView® - Wound Assessment Technology for Predictive Healing Diagnostics

DeepView® Solution: Universal Imaging Platform for Multiple Clinical Indications

DeepView SnapShot® Imaging Platform

Universal Imaging Platform: DeepView allows for multiple clinical indications while providing easy portability across all healthcare settings

AI Predictive Model

• AI algorithm integrates image and clinical data for wound healing prediction
• Images are analyzed against a proprietary clinical database
• Spectral AI has the world’s largest burn biopsy tissue database

Meaningful Clinical Outcomes

• Spectral AI listens to clinicians about challenges and how we can provide meaningful insights that impact patient care
• DeepView strives to transform healthcare by using its proprietary and patented technology
  

Multispectral Imaging and Artificial Intelligence

Currently, there is a lack of diagnostic tools for determining tissue health.

Multispectral imaging allows the physician to extract intrinsic properties and structures of specific tissues which are not visible to the human eye.

Multispectral Imaging Measures Reflectance - Spectral AI system begins its diagnostics by an MSI image capture that sends multiple wavelengths of light from the visible blue field to the deep infrared spectrum. The tissue is illuminated with light of a specific wavelength and the light remitted by the tissue detected.

Multispectral Waveforms Classify Tissue Viability - This remitted light results from the specific absorption properties of the tissue or tissue components and is used to differentiate tissue types.

DeepView® AI Prediction - This multispectral data is combined with patient clinical data to create the input into the DeepView® artificial intelligence algorithm. The result is an accurate, objective wound healing prediction.

Wound Care Solutions for Predictive Healing

DeepView’s Day One prediction eliminates subjective biases and provides a more accurate evaluation of wound healing.

Informed Wound Care Solutions

• Spectral AI’s DeepView® Technology provides accurate information for early determination
• Allows for a clear picture of the wound prior to treatment or other interventions
  

Grab Sources: Company Website. Company Presentation.

-----

Immediate Focus: MDAI's Explosive Potential Catalysts To Watch Closely

Right now, MDAI has multiple potential catalysts that could provide it with a breakout spark in the near term. Here's what to watch for:

#1. A Low Float Could Provide The Potential For Wild Volatility.

Like many of my major breakout alerts in recent memory, MDAI is no different...

It has a low float.

Yahoo Finance is reporting a float of approximately 6.27Mn shares for MDAI which means the potential for volatility is extremely high.

When another potential catalyst, like company news (whether good or bad), can pair with a low float to create a volatile environment allowing a profile to make excessive vertical moves in the blink of an eye.

Which is why it's important to pay attention to companies like MDAI when they drop news like this...

#2. A Game-Changing Contract Awarded To MDAI For Over $100Mn To Advance DeepView® System!

Wow. Take a look at this mind-blowing news announcement:

Spectral MD Awarded BARDA Project BioShield Contract Valued at $149Mn for AI-Driven DeepView® Burn Wound Imaging Technology

DALLAS, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Spectral MD, Inc. (“SMD”), a subsidiary of Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced it has been awarded a new contract valued at up to $149Mn by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services. The contract is for the advanced development of the DeepView® System, the Company’s AI-driven burn wound imaging technology, to be used at emergency departments, trauma centers and burn centers, for both routine burn care and as a medical countermeasure for use in burn mass casualty incidents (BMCI).

...

Read the full article here.

But that's not all this company has been up to. 2023 was a momentous year. Just take a look.

#3. MDAI Looks To Capitalize On A Strong 2023 Full Of Important Company Maneuvers.

This AI company has not been messing around and has been making moves, setting them up for future success.

Here's a quick list of what's happened over the last few months alone:

12/19/23 - Spectral AI Names Industry Veteran and Former Top MiMedx Financial Executive Peter M. Carlson as CFO

10/24/23 - Spectral AI names Prof. Paul Chadwick, Former CEO of the Royal College of Podiatry UK, as Senior Executive for UK and EMEA

10/19/23 - Spectral AI’s DeepView SnapShot® Wound Imaging System, Achieves UKCA Mark and FDA Class 1 Medical Device Classification

And like I said, this is only in the last few months!

What could early 2024 hold for this Nasdaq AI profile?

-----

MDAI Recap - The 3 Top Potential Catalysts To Focus On Now

#1. A Low Float Could Provide The Potential For Wild Volatility.

#2. A Game-Changing Contract Awarded To MDAI For Over $100Mn To Advance DeepView® System!

#3. MDAI Looks To Capitalize On A Strong 2023 Full Of Important Company Maneuvers.

-----

Coverage is officially initiated on Spectral AI, Inc. (MDAI).

When updates are available, I'll get them out to you quickly. Talk soon.

Sincerely,

Kai Parker

StockWireNews

(Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.)